Literature DB >> 14764053

Applications of microarrays to histopathology.

M van de Rijn1, C B Gilks.   

Abstract

High-throughput microarray technologies have the potential to impact significantly on the practice of histopathology over the coming years. Global gene expression profiling allows for a systematic search of all human genes for novel diagnostic and prognostic markers and for potential therapeutic targets. Likewise, gene copy number changes can be determined on a gene-by-gene basis using microarrays. Tissue microarrays are an efficient method to extend and validate the findings obtained from the initial 'discovery' phase of the research, done using cDNA microarrays. In addition, tissue microarrays can be used for quality assurance for immunohistochemical and in situ hybridization procedures. In this review we give a brief overview of microarray technology and research uses, and discuss potential applications of microarrays in the practice of diagnostic histopathology.

Entities:  

Mesh:

Year:  2004        PMID: 14764053     DOI: 10.1111/j.1365-2559.2004.01766.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  16 in total

Review 1.  Tissue microarrays in clinical oncology.

Authors:  David Voduc; Challayne Kenney; Torsten O Nielsen
Journal:  Semin Radiat Oncol       Date:  2008-04       Impact factor: 5.934

2.  Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.

Authors:  Wenjin Chen; David J Foran
Journal:  Anal Chim Acta       Date:  2006-01-23       Impact factor: 6.558

3.  Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.

Authors:  Thomas Knösel; Anna Emde; Karsten Schlüns; Yuan Chen; Karsten Jürchott; Matthias Krause; Manfred Dietel; Iver Petersen
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

4.  Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas.

Authors:  Eric de Kerviler; Cédric de Bazelaire; Nicolas Mounier; Olivier Mathieu; Benoît Brethon; Josette Brière; Jean-Pierre Marolleau; Pauline Brice; Christian Gisselbrecht; Jacques Frija
Journal:  Eur Radiol       Date:  2006-09-26       Impact factor: 5.315

5.  Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer.

Authors:  Jinfeng Zhou; Xing Fan; Ning Chen; Fenli Zhou; Jiaqiang Dong; Yongzhan Nie; Daiming Fan
Journal:  J Histochem Cytochem       Date:  2015-09-15       Impact factor: 2.479

6.  Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.

Authors:  David E Axelrod; Naomi Miller; Judith-Anne W Chapman
Journal:  Biomed Inform Insights       Date:  2009-01-01

7.  Novel molecular imaging platform for monitoring oncological kinases.

Authors:  Shyam Nyati; Brian D Ross; Alnawaz Rehemtulla; Mahaveer S Bhojani
Journal:  Cancer Cell Int       Date:  2010-07-08       Impact factor: 5.722

8.  E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases.

Authors:  Oluwole Fadare; Harini Reddy; Jun Wang; Denise Hileeto; Peter E Schwartz; Wenxin Zheng
Journal:  World J Surg Oncol       Date:  2005-06-21       Impact factor: 2.754

9.  TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles.

Authors:  Andréa Rodrigues Cordovil Pires; Felipe da Matta Andreiuolo; Simone Rabello de Souza
Journal:  Diagn Pathol       Date:  2006-07-25       Impact factor: 2.644

10.  Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection.

Authors:  Nicole Borel; Sanghamitra Mukhopadhyay; Carmen Kaiser; Erin D Sullivan; Richard D Miller; Peter Timms; James T Summersgill; Julio A Ramirez; Andreas Pospischil
Journal:  BMC Infect Dis       Date:  2006-10-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.